132 related articles for article (PubMed ID: 28557615)
21. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
[TBL] [Abstract][Full Text] [Related]
22. Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era.
Glass AS; Cowan JE; Fuldeore MJ; Cooperberg MR; Carroll PR; Kenfield SA; Greene KL
Urology; 2013 Jul; 82(1):60-5. PubMed ID: 23706257
[TBL] [Abstract][Full Text] [Related]
23. Prostate biopsy concordance in a large population-based sample: a Surveillance, Epidemiology and End Results study.
Schreiber D; Wong AT; Rineer J; Weedon J; Schwartz D
J Clin Pathol; 2015 Jun; 68(6):453-7. PubMed ID: 25762729
[TBL] [Abstract][Full Text] [Related]
24. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
Grossfeld GD; Chang JJ; Broering JM; Li YP; Lubeck DP; Flanders SC; Carroll PR
J Urol; 2001 Mar; 165(3):851-6. PubMed ID: 11176485
[TBL] [Abstract][Full Text] [Related]
25. Gleason grading: past, present and future.
Delahunt B; Miller RJ; Srigley JR; Evans AJ; Samaratunga H
Histopathology; 2012 Jan; 60(1):75-86. PubMed ID: 22212079
[TBL] [Abstract][Full Text] [Related]
26. ISUP Group 4 - a Homogenous Group of Prostate Cancers?
Lu TC; Moretti K; Beckmann K; Cohen P; O'Callaghan M
Pathol Oncol Res; 2018 Oct; 24(4):921-925. PubMed ID: 29079965
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
[TBL] [Abstract][Full Text] [Related]
28. PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5.
Patel AA; Chen MH; Renshaw AA; D'Amico AV
JAMA; 2007 Oct; 298(13):1533-8. PubMed ID: 17911498
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of Grading Gleason Score 7 Prostatic Adenocarcinoma on Needle Biopsy: Influence of Percent Pattern 4 and Other Histological Factors.
Meliti A; Sadimin E; Diolombi M; Khani F; Epstein JI
Prostate; 2017 May; 77(6):681-685. PubMed ID: 28155999
[TBL] [Abstract][Full Text] [Related]
30. International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.
Egevad L; Delahunt B; Srigley JR; Samaratunga H
APMIS; 2016 Jun; 124(6):433-5. PubMed ID: 27150257
[TBL] [Abstract][Full Text] [Related]
31. A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score.
Fine SW; Epstein JI
J Urol; 2008 Apr; 179(4):1335-8; discussion 1338-9. PubMed ID: 18289601
[TBL] [Abstract][Full Text] [Related]
32. Modified Gleason grading. An updated review.
Helpap B; Egevad L
Histol Histopathol; 2009 May; 24(5):661-6. PubMed ID: 19283673
[TBL] [Abstract][Full Text] [Related]
33. Correlation between the Gleason scores of needle biopsies and radical prostatectomy specimens.
Shen BY; Tsui KH; Chang PL; Chuang CK; Hsieh ML; Huang ST; Wang TM; Lee SH; Huang HC; Huang SC
Chang Gung Med J; 2003 Dec; 26(12):919-24. PubMed ID: 15008327
[TBL] [Abstract][Full Text] [Related]
34. Interobserver variability in Gleason histological grading of prostate cancer.
Ozkan TA; Eruyar AT; Cebeci OO; Memik O; Ozcan L; Kuskonmaz I
Scand J Urol; 2016 Dec; 50(6):420-424. PubMed ID: 27416104
[TBL] [Abstract][Full Text] [Related]
35. Current practice in handling and reporting prostate needle biopsies: results of a Turkish survey.
Muezzinoglu B; Yorukoglu K
Pathol Res Pract; 2015 May; 211(5):374-80. PubMed ID: 25701362
[TBL] [Abstract][Full Text] [Related]
36. Needle biopsy findings in prostatic adenocarcinoma: experience at a tertiary care center in a developing country.
Ahmad Z; Arshad H
Ann Diagn Pathol; 2013 Jun; 17(3):235-8. PubMed ID: 23199761
[TBL] [Abstract][Full Text] [Related]
37. Contemporary grading for prostate cancer: implications for patient care.
Brimo F; Montironi R; Egevad L; Erbersdobler A; Lin DW; Nelson JB; Rubin MA; van der Kwast T; Amin M; Epstein JI
Eur Urol; 2013 May; 63(5):892-901. PubMed ID: 23092544
[TBL] [Abstract][Full Text] [Related]
38. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists.
Epstein JI; Allsbrook WC; Amin MB; Egevad LL
Adv Anat Pathol; 2006 Jan; 13(1):57-9. PubMed ID: 16462155
[TBL] [Abstract][Full Text] [Related]
39. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?
Makarov DV; Sanderson H; Partin AW; Epstein JI
J Urol; 2002 Jun; 167(6):2440-2. PubMed ID: 11992053
[TBL] [Abstract][Full Text] [Related]
40. Gleason pattern 5 is frequently underdiagnosed on prostate needle-core biopsy.
Al-Hussain TO; Nagar MS; Epstein JI
Urology; 2012 Jan; 79(1):178-81. PubMed ID: 22035764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
